Intravenous Immunoglobulin is Ineffective in the Treatment of Patients with Chronic Fatigue Syndrome
- 1 July 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 103 (1) , 38-43
- https://doi.org/10.1016/s0002-9343(97)90045-0
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Can the chronic fatigue syndrome be defined by distinct clinical features?Psychological Medicine, 1995
- The validity and reliability of the fatigue syndrome that follows glandular feverPsychological Medicine, 1995
- The existence of a fatigue syndrome after glandular feverPsychological Medicine, 1995
- The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and StudyAnnals of Internal Medicine, 1994
- The treatment of chronic fatigue syndrome: Science and speculationThe American Journal of Medicine, 1994
- A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndromeThe American Journal of Medicine, 1990
- A controlled trial of intravenous immunoglobulin G in chronic fatigue syndromeThe American Journal of Medicine, 1990
- The Chronic Mononucleosis SyndromeThe Journal of Infectious Diseases, 1988
- PATHOPHYSIOLOGY OF MYALGIC ENCEPHALITISThe Lancet, 1987
- The postviral fatigue syndrome — an analysis of the findings in 50 casesJournal of Infection, 1985